- Centers & Specialties
- Clinical Interests
- Dysmorphology and syndrome delineation
- Turner's syndrome
- Hereditary Hemorrhagic Telangiectasia (HHT)
- Branchio-oculo-facial syndrome (BOFS)
- Rasopathies: Costello, CFC & Noonan Syndromes
- CHARGE syndrome
- Genetic Support Groups
- Medical Education
- MD, Thomas Jefferson University
- Residency, Children's Hospital of Pittsburgh
- Fellowship, UCLA Medical Center|Fellowship, West Penn Hospital
- Board Certifications
- Clinical Genetics (M.D.)
- Foreign Languages
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - New York
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Adult and Pediatric
Angela E. Lin, MD is a Board-certified pediatrician and clinical geneticist who has dedicated her career to the care of people with physical differences, especially congenital heart defects (CHDs) and syndromes. She has written almost 100 articles and chapters. Dr. Lin attended St. Joseph's University and Thomas Jefferson Medical College in Philadelphia, and completed a pediatric residency at Children's Hospital of Pittsburgh. After fellowship in pediatric cardiology at UCLA, and additional training at the Children's Hospital of Philadelphia, she completed a genetics fellowship at the West Penn Hospital in Pittsburgh. From 1990-1994, she worked at the National Birth Defects Center in Boston. After a maternity leave, she joined the Massachusetts General Hospital in 1997, where she is a Staff Geneticist, and a Clinical Professor in Pediatrics at Harvard Medical School.
In 2011, she and Dr. Lynne Levitsky launched the multi-disciplinary Turner Syndrome Clinic. She has been a member of the Medical Advisory Board of the Turner Syndrome Society of the United States for almost 10 years. She co-founded the MGH HHT Center in 2010 and is the Director. Both clinics serve patients across the lifespan.
Dr. Lin also developed a clinical cardiogenetics service. She is the former Co-Director of the Professional Advisory Committee of the Costello Syndrome Family Network, and sees patients with "rasopathy" syndromes. She works closely with the craniofacial team.
Dr. Lin also works in birth defects surveillance, including the completed National Birth Defects Prevention Study and the new BD Steps program, at the MA Dept. of Public Health. She studies the prevalence of CHDs. She is also an Associate Editor of the American Journal of Medical Genetics.
- Research Summary
- Dr. Lin is a medical geneticist clinical researcher who has delineated clinical and molecular aspects of several malformation syndromes in major reviews (CHARGE, BOFS, Sensenbrenner, MMF embryopathy), as well as contributing cases to define the molecular basis of new syndromes (Myhre syndrome, macrocephly-capillary malformation, auriculo-condylar syndrome, deletion 2q23.1). Her greatest interest has been studying the pattern and frequency of cardiac abnormalities, especially Costello syndrome (and other rasopathy syndromes) and Turner syndrome.
Dr. Lin is a frequent participant in research about birth defects, especially those which are identified through newborn surveillance. These projects have been conducted at the Brigham-Women's Malformation Surveillance Program, and as a consultant to the Massachusetts Center for Birth Defects Prevention. As part of the National Birth Defecs Prevention Study (1997-2013), Dr. Lin has focused on congenital heart defects (CHDs), especially heterotaxy. She is a frequent collaborator in projects studying risk factors for CHDs, classification of CHDs, and currently, is contributing to the analysis of critical CHDs, and CHD prevalence in adults.
Lin AE, et al. 1986. Aortic root dilatation, dissection, and rupture in patients with Turner syndrome. J Peds 109:820.
Lin AE, et al. and the NNFF International Database Participants. Cardiac anomalies in neurofibromatosis, type 1 (NF1). AJMG 2000;95:108.
Lin AE, et al. 2011. Clinical, pathological and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras/MAPK pathway syndrome. AJMG 155:486.
Lin AE, et al. 2013. Sensenbrenner syndrome (Cranioectodermal Dysplasia): Clinical and molecular analyses of 39 patients including two new patients. AJMG Part A 161A:2762.
Lin AE, et al., 2014. Laterality Defects in the National Birth Defects Prevention Study.AJMG 164A:2581
Rosie Mahoney has Turner syndrome, but doesn't let it stop her from dreaming big. With help from the Turner Syndrome Clinic at MassGeneral Hospital for Children, Rosie develops the skills she needs to achieve her dreams.
In addition to practicing clinical genetics at MGHfC, I conduct clinical research in the field of birth defects surveillance. Since 1997, I have been the clinical geneticist consultant to the Massachusetts Department of Public Health Birth Defects Monitoring Program (BDMP).
A first step is taken at a national level to integrate the shared goals of those interested in Turner syndrome.
Boston Globe article profiles Miriam Beit-Aharon, a patient in the MGH Turner Syndrome Clinic, whose mother, Claudette, edited a collection of essays of women living with Turner syndrome. The article mentions Co-Director Dr. Angela Lin, and her interest in the use of IVF for women with Turner syndrome.
Opened in October of 2011 under the leadership of medical geneticist Angela Lin, MD, and Lynne L. Levitsky, MD, chief of pediatric endocrinology at MassGeneral Hospital for Children (MGHfC) and joined by reproductive endocrinologist Frances Hayes, MD, in 2013, the Turner Syndrome Clinic at MGHfC provides comprehensive evaluation and individualized care for newborns, toddlers and adolescents with Turner syndrome.
185 Cambridge St
Simches Research Center
Boston MA, 02114